B4GALT3 Antibody (Center) Blocking Peptide

Produktübersicht

• Artikelname: B4GALT3 Antibody (Center) Blocking Peptide
• Artikelnummer: ABT-BP8977C
• Hersteller Artikelnummer: BP8977c
• Alternativnummer: ABT-BP8977C-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: Beta-1,4-galactosyltransferase 3, Beta-1,4-GalTase 3, Beta4Gal-T3, b4Gal-T3, 241-, UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3, UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3, N-acetyllactosamine synthase, Nal synthase, Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase, Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase, 241-, B4GALT3

Produktbeschreibung

B4GALT3 is responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids.

Produkteigenschaften

• NCBI: 8703
• UniProt: O60512
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP8977c was selected from the Center region of human B4GALT3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.